Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study
Graphical Abstract Keywords Hepatocellular carcinoma, Fluorescence-guided surgery, Fluorescent probes, Indocyanine green, Aggregation-induced emission luminogens, Surgical navigation Introduction Hepatocellular carcinoma (HCC) is a significant public health concern worldwide
That means theres no clear winner when it comes to having fewer side effectsthe differences are relatively small and often come down to how your body responds
doi: 10.1016/bs.pmbts.2018.07.008
10.1093/carcin/bgt392 Carcinogenesis 18 CaniP
For liver health Liver fat reduction begins relatively early in treatment, but MASH resolution and fibrosis improvement require sustained therapy